VERINTEX sol cutanée fl 20 ml

7680554450020 CH-55445 20.01.2.
VERINTEX sol cutanée fl 20 ml
VERINTEX sol cutanée fl 20 ml
VERINTEX sol cutanée fl 20 ml
1 / 3
google

Details

Product number
5544501
CPT
-
Packaging group
20
Unit
ml
Composition
anagallis arvensis (HAB) D4 210 mg, ruta graveolens ex herba cum floribus spag. Peka D6 (HAB 47a) 204 mg, smilax (HAB) D10 210 mg, semecarpus anacardium (HAB) D4 165 mg, sempervivum tectorum var. tectorum e folio spag. Peka D6 (HAB 47a) 101 mg, thuja occidentalis (HAB) D12 110 mg, ethanolum 96 per centum, aqua purificata, ad solutionem pro 1 g, corresp. 1.04 ml, corresp. ethanolum 28 % V/V.

Articles (1)

Verintex, Flüssigkeit zur Anwendung auf der Haut
Flüssigkeit
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/11/2024
Patient information leaflet
Français
12/11/2024
Patient information leaflet
Italien
12/11/2024

Detailed composition

Substance Quantity Type Category
(N/A)
210.0 MG Substance Wirkstoff (Principe actif)
(N/A)
204.0 MG Substance Wirkstoff (Principe actif)
(N/A)
210.0 MG Substance Wirkstoff (Principe actif)
(N/A)
165.0 MG Substance Wirkstoff (Principe actif)
(N/A)
101.0 MG Substance Wirkstoff (Principe actif)
(N/A)
110.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

ebi-pharm ag

3038 Kirchlindach

Authorization information

Swissmedic authorization number
55445
Drug name
Verintex, Flüssigkeit zur Anwendung auf der Haut
Galenic form
FLUK
Authorization status
Z
Dispensation category
D
First authorization
22/06/2000
Authorization expiration date
31/12/9999
IT number
20.01.2.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild und dem Therapieprinzip der Spagyrik bei Warzen.

Packaging details

Description (FR)
VERINTEX sol cutanée fl 20 ml
Description (DE)
VERINTEX Lös z Anwendung auf der Haut Fl 20 ml
Market launch
22/06/2000
Narcotic (BTM)
No